Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Excipient Effects on Cimetidine Absorption
NCT01256879Phase 4Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Mar 2011
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cimetidine in Peptic ulcer disease (PUD), gastroesophageal reflux disease (GERD), sponsored by University of Maryland, Baltimore. Started Mar 2011; status: completed.
02
Drugs
cimetidine
03
Conditions
Peptic ulcer disease (PUD)gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01256879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01256879.